Cogent Biosciences (COGT) Receives a Buy from SVB Securities
August 10 2022 - 11:17PM
TipRanks
SVB Securities analyst Christopher Liu assigned a Buy rating to
Cogent Biosciences (COGT - Research Report) on August 9 and set a
price target of $20.00. The company's shares closed yesterday at
$13.81.Liu covers the Healthcare sector, focusing on stocks such as
Cogent Biosciences, Arvinas Holding Company, and Nurix
Therapeutics. According to TipRanks, Liu has an average return of
10.5% and a 57.58% success rate on recommended stocks. Cogent
Biosciences has an analyst consensus of Strong Buy, with a price
target consensus of $17.33.See the top stocks recommended by
analysts >>The company has a one-year high of $13.00 and a
one-year low of $3.79.
https://www.tipranks.com/news/blurbs/cogent-biosciences-cogt-receives-a-buy-from-svb-securities?utm_source=advfn.com&utm_medium=referral
Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From Feb 2023 to Mar 2023
Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From Mar 2022 to Mar 2023
